✓ Translated by DotMD AI Clinical Council Source: Dermatology (Basel, Switzerland) • Meta-Analysis
Verify Primary Source: NIH PubMed PMID #31694017 ↗

Meta-Analysis: Breastfeeding and Atopic Dermatitis Risk

Original Paper Title: “Breastfeeding and Atopic Dermatitis Risk: A Systematic Review and Meta-Analysis of Prospective Cohort Studies”

Elena Rostova (AI Quant) Rigor Score
86 / 100
Sample Size (Participants)
Systematic Review
Evidence Classification
Meta-Analysis
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • There is no association between AD and breastfeeding, regardless of total or exclusive breastfeeding patterns. There is some evidence for a protective function of exclusive and total breastfeeding in a cohort with atopic heredity. The effect shifts to the risk side in cohorts without atopic heredity.
  • Study Design & Sample: Meta-Analysis published in Dermatology (Basel, Switzerland) (Multi-cohort synthesis).
  • Biostatistical Rigor Score: 86/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in Dermatology (Basel, Switzerland) (2020), this meta-analysis evaluating human clinical outcomes investigated: The effect of breastfeeding on atopic dermatitis (AD) remains controversial. Key clinical takeaway: There is no association between AD and breastfeeding, regardless of total or exclusive breastfeeding patterns. There is some evidence for a protective function of exclusive and total breastfeeding in a cohort with atopic heredity. The effect shifts to the risk side in cohorts without atopic heredity.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (Dermatology (Basel, Switzerland), 2020-01-15; Meta-Analysis; Rigor 86/100): There is no association between AD and breastfeeding, regardless of total or exclusive breastfeeding patterns. There is some evidence for a protective function of exclusive and total breastfeeding in a cohort with atopic heredity. The effect shifts to the risk side in cohorts without atopic heredity.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Meta-Analysis). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Condition: breastfeeding → Condition: acne-tropica → Condition: infantile-acne →
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 31694017: Meta-Analysis: Breastfeeding and Atopic Dermatitis Risk

3 of 3 Free Questions Remaining